Plain to See: New contrast agents for magnetic resonance imaging of tumors

May 7, 2010

( -- Magnetic resonance imaging (MRI) is primarily a medical imaging technique that is used to visualize different soft tissues within the body. In the field of cancer therapy, a contrast agent is often used to help identify the exact location of tumor cells. As reported in the European Journal of Organic Chemistry, a team led by Carlos Platas-Iglesias and Teresa Rodríguez-Blas from the Universidade da Coruna has recently designed a new set of receptors that may be useful in the design of specific MRI contrast agents for the recognition of certain compounds on the surfaces of tumor cells.

Specific contrast agents that are able to report on their biological environments through molecular recognition processes are highly desired. A specific MRI contrast agent could take advantage of these processes to respond to certain functional groups that can be found in abundance in the diseased tissue. Sialic acid, for instance, is considered to be a tumor marker, because it is known to be over-expressed on the surfaces of . An MRI contrast agent specific for sialic acid should bind selectively with the acid in preference to other sugar residues and to saccharides such as glucose and fructose, which occur in relatively high concentrations in the blood.

Platas-Iglesias and Rodríguez-Blas reasoned that a suitable receptor for sialic acid recognition might be based on (thio)urea units containing boronic acid functions, as both of these functionalities show promise as recognition moieties. (Thio)Urea-based receptors can establish strong interactions with anions such as carboxylates, which are present in sialic acids, and boronic acids are able to form reversible complexes with 1,2- and 1,3-diol units present in saccharides.

To test their receptors, the authors monitored their binding to Neu5Ac, which is the most common member of the sialic acid family; it also plays an important role in cellular recognition processes. The receptors were found to bind to Neu5Ac, and importantly, much weaker interaction between the receptors and other saccharides studied was observed. The selectivity was found to occur by cooperative two-site binding of Neu5Ac through (1) interaction at the boronic acid function of the receptor and (2) interaction between the thiourea moiety and the carboxylate group of Neu5Ac. The set of receptors have thus been shown to interact selectively with targets over-expressed on the surface of cancer cells, which makes them promising synthons for the design of specific contrast agents for MRI of tumors.

Explore further: New technique developed for tracking cells in the body

More information: Carlos Platas-Iglesias, Towards Selective Recognition of Sialic Acid Through Simultaneous Binding to Its cis-Diol and Carboxylate Functions, European Journal of Organic Chemistry,

Related Stories

New technique developed for tracking cells in the body

March 20, 2007

Scientists' inability to follow the whereabouts of cells injected into the human body has long been a major drawback in developing effective medical therapies. Now, researchers at Johns Hopkins have developed a promising ...

Targeting tumors the natural way

March 25, 2007

By mimicking Nature's way of distinguishing one type of cell from another, University of Wisconsin-Madison scientists now report they can more effectively seek out and kill cancer cells while sparing healthy ones.

Better Insight into Brain Anatomical Structures

May 29, 2007

Magnetic resonance imaging is a very effective method for revealing anatomical details of soft tissues. Contrast agents can help to make these images even clearer and allow physiological processes to be followed in real time. ...

Better insight into brain anatomical structures

June 15, 2007

Magnetic resonance imaging is a very effective method for revealing anatomical details of soft tissues. Contrast agents can help to make these images even clearer and allow physiological processes to be followed in real time. ...

Self-Assembling Nanoparticles Image Tumor Cells

July 23, 2007

By taking advantage of the full range of ways in which molecules can interact with and bind to one another, a team of investigators at the Carolina Center of Cancer Nanotechnology Excellence has created nanoparticles that ...

Nanoparticles Unlock Tumor Identity

March 28, 2010

( -- Using nanoparticles designed to recognize specific sugar-binding molecules on the surfaces of cells, a team of investigators at Michigan State University has developed a process that uses magnetic resonance ...

Recommended for you

A new form of real gold, almost as light as air

November 25, 2015

Researchers at ETH Zurich have created a new type of foam made of real gold. It is the lightest form ever produced of the precious metal: a thousand times lighter than its conventional form and yet it is nearly impossible ...

Getting under the skin of a medieval mystery

November 23, 2015

A simple PVC eraser has helped an international team of scientists led by bioarchaeologists at the University of York to resolve the mystery surrounding the tissue-thin parchment used by medieval scribes to produce the first ...

Moonlighting molecules: Finding new uses for old enzymes

November 27, 2015

A collaboration between the University of Cambridge and MedImmune, the global biologics research and development arm of AstraZeneca, has led researchers to identify a potentially significant new application for a well-known ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.